top of page
RTK crop.jfif


Corporate Financial Advisor and Board Level structuralist for Financial Analysis, Reporting, Accounting, Management Consulting, Healthcare Consulting and Corporate Law.  Financial executive and business consultant as Principal of a successful investment banking firm and legal advisory group, managing companies from startup to $40,000,000 in annual revenues in the biotech/life science, ophthalmic, and renewable energy sectors.

Internationally-recognized cardiologist, inventor, educator, author and one of the early pioneers of the angioplasty procedure. Author of over 180 research studies, clinical textbooks, and author of 24 granted patents. Scientific Advisory Board Chair for ValveCure; Professor of Medicine at the University of Arizona College of Medicine; Founder of the Phoenix Heart & Lung Center; Vascular Heart & Lung Associates, PC; Principal Investigator: 100+ medical device studies and 50 pharmaceutical studies.


Rob Kirk, JD, OD


John Osth

CEO of NanoSomix; previously CEO of Celula, Inc.; Chairman & CEO of QuantumCor Inc., of which he was a founder. John has also held senior level positions at Baxter Healthcare including President of the Immunotherapy Division and head of European R&D. 

Jeffrey Hlozek 

Dennis Hlozek

Principal and founder of sales and marketing representative companies focusing on Acute Care, Critical Care, OR, Cath Lab, ED, Wound Care, and Bio Medical Engineering in the surgical and minimally invasive markets.  Board and C-Suite oversight consultant adjunctive to Manufacturer's Representative engagements. 

SAB Cardiologist and Cardio Thoracic physician member access only through Dr. Heuser.


Scientific Advisory Board

  • Richard Heuser, MD 
  • David Adams, MD 
  • Peter Block, MD
  • Randy Chitwood, MD
  • Saibal Kar, MD
  • Jeffrey Milliken, MD


Richard Heuser, MD, FACC, FACP, FESC, FSCAI

C-Suite executive in companies developing enterprise product design, delivery and implementation availability in the market of health care data and analytics, with special emphasis on the cutting edge integration of universal availability and access for patient healthcare information.

Most recently CEO of Mind & Associates, Inc., Edward has been a senior level business executive, founder and Director of interventional and surgical/medical minimally invasive companies in cardiac, neurologic, orthopedic, urologic, gynecologic and ENT companies.

He has been responsible for financial and clinical introductory oversight for Class I, II & III devices for minimally invasive devices and techniques in all surgical specialties, including RF therapy devices. Designer and patent holder for the current transcatheter platform technologies of ValveCure.

Edward Hlozek, CEO and Chairman

bottom of page